Chronic heart diseases as the most prevalent comorbidities among deaths by COVID-19 in Brazil

ABSTRACT Age, sex and presence of comorbidities are risk factors associated with COVID-19. Hypertension, diabetes and heart disease are the most common comorbidities in patients with COVID-19. The objective of this study was to estimate the prevalence of patients with comorbidities who died of COVID...

Full description

Bibliographic Details
Published in:Revista do Instituto de Medicina Tropical de São Paulo
Main Authors: Julianne Pachiega, Alexandre José dos Santos Afonso, Géssica Thaís Sinhorin, Bianca Teshima de Alencar, Marta dos Santos Miranda de Araújo, Fabiana Gulin Longhi, Andernice dos Santos Zanetti, Omar Ariel Espinosa
Format: Article in Journal/Newspaper
Language:English
Published: Universidade de São Paulo (USP) 2020
Subjects:
COVID-19
Prevalence
Deaths
Comorbidities
Brazil
Heart disease
Diabetes
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
Arctic
Online Access:https://doi.org/10.1590/s1678-9946202062045
https://doaj.org/article/60ee1e6a0c42406fad984c726aebe9dc
Description
Summary:ABSTRACT Age, sex and presence of comorbidities are risk factors associated with COVID-19. Hypertension, diabetes and heart disease are the most common comorbidities in patients with COVID-19. The objective of this study was to estimate the prevalence of patients with comorbidities who died of COVID-19 in Brazil. Searches of data were carried out on the official pages of the 26 State health departments and the federal district. The random-effect method was used to calculate the prevalence of patients with comorbidities who died. From the beginning of the pandemic in Brazil until May 20, 2020, 276,703 cases of COVID-19 were notified in Brazil, 6.4% died, 58.6% of whom were male. The prevalence of comorbidities among deaths was 83% (95% CI: 79 - 87), with heart disease and diabetes being the most prevalent. To our knowledge, this study represents the first large analysis of cases of patients with confirmed COVID-19 in Brazil. There is a high prevalence of comorbidities (83%) among patients who died from COVID-19 in Brazil, with heart disease being the most prevalent. This is important considering the possible secondary effects produced by drugs such as hydroxychloroquine.

Similar Items